...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Sabizabulin - mCRPC- used now for Covid 19.

Sold to anyone  of the BP who want to be a pioneer in this   futuristic medicine , Who knows Epigenetics could be the next new and improved  CRISPR technology in biotech ......

Share
New Message
Please login to post a reply